[Justice Prabha Sridevan] Today the judicial authority may be faced with balancing patent rights and patients’ rights or right to life. It shall use all the tools at its command and innovate if necessary, but shall rule in favour of life.
[Germán Velásquez] The unprecedented global health crisis caused by the coronavirus (COVID-19) pandemic since the first quarter of 2020 has reopened the now-urgent discussion about the role of local pharmaceutical production in addressing the health needs in developing countries. The COVID-19 crisis has highlighted the interdependencies in the global production of pharmaceuticals—no country is self-sufficient.
[Diane Peters and Eric Steuer] We’re pleased to announce today that Creative Commons is taking on leadership and stewardship of the Open COVID Pledge. Earlier this year, CC joined forces with an international group of researchers, scientists, academics, and lawyers seeking to accelerate the development of diagnostics, vaccines, therapeutics, medical equipment, and software solutions that might be used to assist in the fight against COVID-19. The result was the Open COVID Pledge, a project that offers a simple way for universities, companies, and others to make their patents and copyrights available to the public to be utilized in the current public health crisis. Users of Creative Commons licenses will be familiar with the Open COVID Pledge’s approach. Like CC licenses, the Open COVID Pledge offers free, standard, public licenses that anyone can use to remove unnecessary obstacles to the dissemination of knowledge.
[Frederick Abbott] Abstract: The COVID-19 pandemic has caused Governments to contemplate measures to override patents and other intellectual property rights (IPRs) in order to facilitate production and distribution of vaccines, treatments, diagnostics and medical devices. This paper discusses whether the COVID-19 pandemic may be considered an “emergency in international relations” and how WTO Member States may invoke Article 73 (“Security Exceptions”) of the TRIPS Agreement as the legal basis for overriding IPRs otherwise required to be made available or enforced. It concludes that the pandemic constitutes an emergency in international relations within the meaning of Article 73(b)(iii) and that this provision allows Governments to take actions necessary to protect their essential security interests.
[Jorge L. Contreras] Abstract: Two competing and linked sets of goals must be addressed when considering patent policy in response to a public health emergency. First is the allocation of existing resources among potential users (hospitals, patients, etc.); second is the creation of new technologies over time (innovation).
[Webinar - Sep 15, 2020; 10:00am] MedsPaL is the Medicines Patent Pool (MPP)’s patents and licenses database, a free resource provides information on the intellectual property status of selected patent essential medicines in low- and middle-income countries (LMICs). The database includes patent and licensing data covering over 8,500 national patent applications on 110 priority medicines (220 formulations) in more than 130 LMICs. In March 2020, it was expanded to provide patent information on treatments currently being tested for COVID-19. The database is available at www.medspal.org.
[Teresa Hackett] In Part II of this two-part blog, EIFL Copyright and Libraries Programme Manager Teresa Hackett examines how the COVID-19 pandemic has highlighted the importance of the right to research through two key issues, text and data mining and digital preservation by cultural heritage institutions, and how WIPO’s proven formula could address the issues. In Part 1 of the blog, we looked at the immediate challenges the COVID-19 pandemic posed for the copyright and licensing framework as education moved online.
Thanks to Ante Wessels for calling to my attention to an EU Trade Policy Review, which aims "to build a consensus around a fresh medium-term direction for EU trade policy, responding to a variety of new global challenges and taking into account the lessons learned from the coronavirus crisis." The review includes a request for comments from the public, with submissions due September 15.
[Nirmalya Syam] A regular session of the TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) Council was held virtually on 30 July 2020. This session offered the first opportunity for the World Trade Organization (WTO) Members to discuss intellectual property (IP) related issues in the context of COVID-19. Discussions focused on national measures taken by various countries in relation to IP in response to COVID-19 as well as the scope of the use of TRIPS flexibilities across the spectrum of various IP rights in order to ensure rapid development, scaled up manufacturing of and affordable, timely and equitable access to various technologies and products required to respond to COVID-19. South Africa made a strong general statement pointing to the need to consider new bold measures that will comprehensively and expeditiously address IP challenges.
Research Symposium, QUT Faculty of Law, 29 July 2020 Overview This event will consider the relationship between intellectual property and higher education in the age of the public health crisis over the coronavirus COVID-19. It will bring together scholars, experts,…
[Ana Santos Rutschman] Abstract: Vaccines have long played a crucial role in the prevention, mitigation and eradication of infectious diseases. More than any other recent outbreak, the COVID-19 pandemic has brought the phenomenon of the vaccine race to the forefront of personal, national and global preoccupations. This symposium contribution examines the early features and takeaways of the COVID-19 vaccine race in four parts.
[Francisco Colman Sercovich] ...The markets of the poorest countries, those most affected by prior pandemics thus far, are not profitable enough for wealthy countries-based multinationals to justify engaging in vaccine R&D. Beyond health-related imperatives, the large subsidies being swiftly granted by wealthy countries now in order to not just shorten schedules but also, perhaps for the most part, to ensure domestic production capacity and control of intellectual property rights, are a glaring recognition of the market failures involved and the ensuing need for public intervention -- albeit often tinted by a narrow-minded nationalism.